Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $2.42 Million - $4.04 Million
57,000 Added 626.37%
66,100 $4.5 Million
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $5.35 Million - $9.62 Million
-129,500 Reduced 93.43%
9,100 $384,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $6.63 Million - $8.69 Million
117,800 Added 566.35%
138,600 $9.57 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $3.25 Million - $4.16 Million
-55,000 Reduced 72.56%
20,800 $1.54 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $2.48 Million - $3.75 Million
39,500 Added 108.82%
75,800 $7.12 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $1.71 Million - $2.57 Million
36,300 New
36,300 $2.46 Million
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $1.13 Million - $1.62 Million
-19,600 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $1.63 Million - $2.17 Million
14,000 Added 250.0%
19,600 $2.58 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $557,816 - $795,872
5,600 New
5,600 $742,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.